Chester County News and Community Website
Zynerba Pharmaceuticals (NASDAQ: ZYNE), headquartered in Devon, Pennsylvania, is the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. The company is committed to improving the lives of patients and their families living with severe, chronic health conditions including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. Learn more at www.zynerba.com and follow them on Twitter at @ZynerbaPharma.
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), a pharmaceutical company, recently announced a definitive agreement to acquire Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), a leader in innovative pharmaceutically-produced …
Harmony Biosciences to Acquire Zynerba Pharmaceuticals Read More
DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced that the new date for the adjourned 2023 Annual Meeting of Stockholders is August 25, 2023, at 9:00 a.m. EDT in …
Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting Read More DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced that the new date for the adjourned 2023 Annual Meeting of Stockholders is August 11, 2023, at 9:00 a.m. EDT in …
Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting Read More DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced that Armando Anido, Chairman and Chief Executive Officer of Zynerba, will present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference …
Zynerba Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference Read More DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced an oral podium presentation and poster presentations at the American Society of Clinical Psychopharmacology Annual Meeting (ASCP 2023), being held May …
Zynerba Pharmaceuticals to Showcase Cutting-Edge Cannabinoid Therapies for Neuropsychiatric Disorders at ASCP 2023 Read More DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced the presentation of two posters at the 55th Gatlinburg Conference, being held April 10-13, 2023, in Kansas City, Mo. Copies of the …
Zynerba Pharmaceuticals Announces Poster Presentations at the 55th Gatlinburg Conference Read More DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE)this week reported financial results for the fourth quarter and full year ended December 31, 2022, and provided an overview of recent operational …
Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results Read More DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) recently announced two poster presentations at the 18th NFXF International Fragile X Conference, being held July 14-17, 2022, in San Diego, Calif. …
Zynerba Pharmaceuticals Announces Panel Presentation and Poster Presentations at the NFXF International Fragile X Conference Read More